MYD Stock Price, Chart, Stats & News

Myriad Genetics, Inc. is a prominent player in the genetic testing and precision medicine sector, developing and commercializing diagnostic solutions across the United States and globally. Its extensive portfolio encompasses molecular diagnostic tests tailored for oncology, women's health, and mental well-being. Among its notable cancer diagnostics is the MyRisk Hereditary Cancer Test, a DNA sequencing-based tool designed to assess an individual's susceptibility to inherited cancers.